its true , its a combination of many things going on , I guess the small shale explorers are taking it on the chin, or if you men prefer up something .
Daory,,,You already owe me a drink .
The amazing thing is that low oil prices should be a good thing for all companies except oil co's
The real problem is that it indicates a world slow down . Bio's should not be hurt y all this BS , but the money manipulators are busy doing what they do best making a fortune while the little guy gets screwed .
By Emma Court
Shares of Arbutus Biopharma, SteadyMed and Endocyte are trading below cash value
The recent carnage in biotechnology stocks has created a number of opportunities for investors to buy into the sector on the cheap, according to RBC Capital.
Analysts at RBC have compiled a list of biotech stocks trading below, or just slightly above cash levels, which could signal a "floor" for the stocks, or make them potential buyout targets for value investors.
A stock trading at a company's cash level implies the market is assigning little or no value to the biotech assets they own.
"Broadly speaking, many investors can be attracted to this type of stock because it implies that a biotech asset may be getting little to no value if it's trading at cash on the balance sheet, which may be theoretically irrational given there should be some value for a drug and could work driving upside from current levels," RBC analysts wrote in a research note to clients.
After screening the stocks of about 50 biotech companies covered by RBC, the analysts found three that were trading below cash levels:
-- SteadyMed Ltd. (STDY)
-- Endocyte, Inc. (ECYT)
-- Arbutus Biopharma Corporation (ABUS)
Among other stocks RBC found to be trading at a fraction of cash levels:
-- Esperion Therapeutics Inc. (OREX)--0.3-times cash
-- Zafgen Inc. (ZFGN)--0.3-times cash
-- Scynexis Inc. (SCYX)--0.3-times cash
-- Nabriva Therapeutics AG (NBRV)--0.4-times cash
-- Aptose Biosciences Inc. (APTO)--0.6-times cash
-- Ocular Therapeutix Inc. (OCUL)--0.6-times cash
-- VIVUS Inc. (VVUS)--0.7-times cash
-- Orexigen Therapeutics Inc. (OREX)--0.9-times cash
Your a funny guy, wish I could have found you for that drink or two or more
probably would help forgetting kerx for the moment , but than would have ended up with a headache .
This will never move over $5 unless we see some earth breaking news .
The shorts got us by the throat , big money has been making a fortune on this manipulation and they won't let go .
The weather is terrible , will be lucky to get home and have a drink , maybe I'll stop in a lounge and get stranded . to cold for bikini's , looks like everything is not turning up roses .
This price action will never get me on that yacht basking in the sun,
With all those sales people out there scripts should be twice what they are .
Janet : ( , where is my drink
thank you Daory , compliments will get you every where .
I like several types of drinks , bourbon old fashion , white Russian, bloody Mary,
i'll try anything .
Janet ; )